Medincell
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 --
業務概覽 Medincell SA is a technology-based pharmaceutical firm, aims to optimise the efficiency of medical treatments and make them accessible geographically. The company's product portfolio uses BEPO-patented technology to develop controlled, long-acting injectable medical treatments for a number of therapeutic fields. The firm has a single operating segment: ongoing research and development on processes that use biodegradable polymers to enable the controlled and prolonged releaseof the active principles of drugs into the human body and animals by means of injection.
公司地址 3 rue des Freres Lumiere, Jacou, FRA, 34830
電話號碼 +33 144719494
傳真號碼 --
公司網頁 https://www.medincell.com
員工數量 143
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Christophe Douat Director and Chief Executive Officer -- 30/07/2025
 
董事會成員
董事會 職務 更新日期
Mr. Christophe Douat Director and Chief Executive Officer 30/07/2025
Ms. Tone Kvale Member of the Supervisory Board 30/07/2025
Dr. Pascal Touchon, D.V.M. Member of the Supervisory Board 30/07/2025
Mr. Philippe Guy Chairman of the Supervisory Board 30/07/2025
Ms. Virginie Lleu Member of the Supervisory Board 30/07/2025
Ms. Elisabeth Kogan Vice Chairman of the Supervisory Board 30/07/2025
 
所屬ETF (更新日期: 07/03/2026 03:08)
代號 名稱 佔比% ▼ 持有日期
GWXState Street® SPDR® S&P® Intl Sm Cp ETF0.03%27/02/2026
AVDEAvantis International Equity ETF0.02%28/02/2026
CHWCalamos Global Dynamic Income0.01%31/12/2025
CGOCalamos Global Total Return0.005%31/12/2025
SPEUState Street® SPDR® Portfolio Europe ETF0.004%27/02/2026
IBRNiShares Neuroscience and Healthcare ETF0.004%28/02/2026
DBEZXtrackers MSCI Eurozone Hedged Eq ETF0.001%26/02/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF0.0002%27/02/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.